Pyridazino[4,5-b]quinolinediones: Novel glycine/N-methyl-D-aspartate antagonists for the treatment of stroke

Journal of Heterocyclic Chemistry

Volumn 35, Issue 5, 1998, Pages 1171-1186

  Bare, Thomas M ^a  

^a ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 4 PHOSPHONOMETHYL 3 HEPTENOIC ACID; 4 PHOSPHONOMETHYLPIPECOLIC ACID; 6,7 DICHLORO 5 NITRO 2,3 QUINOXALINEDIONE; 7 CHLORO (4' METHOXY 2' METHYLPHENYL) 1,2,5,10 TETRAHYDROPYRIDAZINO[4,5 B]QUINOLINE 1,10 DION 4 ENOLATE SODIUM; 7 CHLORO 4 HYDROXY 2 (4 METHOXY 2 METHYLPHENYL) 1,2,5,10 TETRAHYDROPYRIDANIZO[4,5 B]QUINOLINE 1,10 DIONE; APTIGANEL; CGP 19755; EXCITATORY AMINO ACID; GLYCINE RECEPTOR ANTAGONIST; KYNURENIC ACID DERIVATIVE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PYRIDAZINO[4,5 B]QUINOLINEDIONE DERIVATIVE; UNCLASSIFIED DRUG;

BRAIN PROTECTION; CONFERENCE PAPER; DRUG ACTIVITY; DRUG BIOAVAILABILITY; DRUG DETERMINATION; DRUG EFFECT; DRUG HALF LIFE; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; DRUG SOLUBILITY; DRUG STABILITY; DRUG SYNTHESIS; HALLUCINATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PHYSICAL CHEMISTRY; STROKE; STRUCTURE ACTIVITY RELATION;

EID: 0031771582     PISSN: 0022152X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jhet.5570350513     Document Type: Conference Paper

References (58)

1. J. A. Zivin and D. W. Choi, Scientific American, 265, 56 (1991).
2. G. Boysen and T. Truelsen, Lancet, 351, 1073 (1998).
3. D. B. Matchar and P. W. Duncan, Stroke: Clinical Updates, 5(3), 9 (1994).
4. Heart and Stroke Facts, American Heart Association 1995.
5. L. R. Caplan, Lancet, 339, 656 (1992).
6. L. M. Pullan, in Neurotherapeutics: Emerging Strategies, L. Pullan and J. Patel, eds, Humana Press Inc., Totowa, NJ, 1995, pp 275-322.
7. B. K. Siesjo and B. Bengtsson, J. Cereb. Blood Flow Metab., 9, 127 (1989).
8. B. K. Siesjo, J. Neurosurg., 77, 169 (1992).
9. W. Pulsinelli, Scientific American, SCIENCE & MEDICINE 2, 16 (1995).
10. H. Benveniste, J. Drejer, A. Schousboe and N. H. Diemer, J. Neurochem., 43, 1369 (1984).
11. L. Hillered, A. Hallstrom, S. Segersvard, L. Persson and U. Ungerstedt, J. Cereb. Blood Flow Metab., 9, 607 (1989).
12. D. W. Choi, Trends Neurosci., 11, 465 (1988).
13. J. W. Olney, R. C. Collins and R. S. Sloviter, Adv. Neurol., 44, 857 (1986).
14. R. P. Simon, J. H. Swan, T. Griffiths and B. S. Meldrum, Science, 226, 850 (1984).
15. G. E. Fagg and L. Massieu, in Excitatory Amino Acid Antagonists, B. S. Meldrum, ed, Blackwell, Oxford, 1991, pp 39-63.
16. T. Knopfel, R. Kuhn and H. Allgeier, J. Med. Chem., 38, 1417 (1995).
17. D. W. Choi, in Excitatory Amino Acid Antagonists, B. S. Meldrum, ed, Blackwell, Oxford, 1991, pp 216-236.
18. W. Danysz, C. G. Parsons, I. Bresink and G. Quack, Drug News & Perspectives, 8, 261 (1995).
19. D. W. Choi, J-Y. Koh and S. Peters, J. Neurosci., 8, 185 (1988).
20. B. Meldrum and J. Garthwaite, Trends Pharmacol. Sci., 11, 379 (1990).
21. J. Willetts, R. L. Balster and D. J. Leander, Trends Pharmacol. Sci., 11, 423 (1990).
22. W. Koek and F. C. Colpaert, J. Pharmacol. Exp. Ther., 252, 349 (1990).
23. J. A. Kemp and P. D. Leeson, Trends Pharmacol. Sci., 14, 20 (1993).
24. J. W. Johnson and P. Ascher, Nature, 325, 529 (1987).
25. N. W. Kleckner and R. Dingledine, Science, 241, 835 (1988).
26. P. J. Birch, C. J. Grossman and A. G. Hayes, Eur. J. Pharmacol., 154, 85 (1988).
27. M. Kessler, M. Baudry and G. Lynch, Brain Res., 489, 377 (1989).
28. J. A. Kemp, A. C. Foster, P .D. Leeson, T. Priestley, R. Tridgett, L. L. Iversen and G. N. Woodruff, Proc. Nat. Acad. Sci. U.S.A., 85, 6547 (1988).
29. P. D. Leeson and L. L. Iversen, J. Med. Chem., 37, 4053 (1994).
30. L. M. Pullan and R. J. Powel, Neurosci. Letters, 148, 199 (1992).
31. M. A. Sills, G. Fagg, M. Pozza, C. Angst, D. E. Brundish, S. D. Hunt, E. J. Wilusz and M. Williams, Eur. J. Pharmacol., 192, 19 (1991).
32. W. F. Hood, E. T. Sun, R. P. Compton and J. B. Monahan, Eur. J. Pharmacol., 161, 281 (1989).
33. J. Lehmann, A. J. Hutchison, S. E. McPherson, C. Mondadori, M. Schmutz, C. M. Sinton, C. Tsai, D. E. Murphy, D. J. Steel, M. Williams, D. L. Cheney and P. L. Wood, J. Pharmacol. Exp. Therap., 246, 65 (1988).
34. J. M. Goldstein, L. M. Koch, L. C. Litwin and A. I. Salama, Neurosci. Abstr., 15, 201 (1989).
35. S. Brint, M. Jacewicz, M. Kiessling, J. Tanabe and W. Pulsinelli, J. Cereb. Blood Flow Metab., 8, 474 (1988).
36. J. B. Patel, L. Ross, S. Siddiqui, L. Walczak, T. M. Bare, M. Asif and B. Duncan, Neurosci. Abstr., 19, 1645 (1993).
37. B. Bose, J. L. Osterholm and R. Berry, Brain Res., 311, 385 (1984).
38. J. B. Bederson, L. H. Pitts, S. M. Germano, M. C. Nishimura, R. L. Davis and H. M. Bartowski, Stroke, 17, 1304 (1986).
39. P. D. Leeson, R. Baker, R. C. Carling, N. R. Curtis, K. W. Moore, B. J. Williams, A. C. Foster, A. E. Donald, J. A. Kemp and G. R. Marshall, J. Med. Chem., 34, 1243 (1991).
40. T. M. Bare, C. D. McLaren, J. B. Campbell, J. W. Firor, C. P. Walters, A. I. Salama, B. A. Meiners and J. B. Patel, J. Med. Chem., 32, 2561 (1989).
41. T. M. Bare and R. B. Sparks, European Patent 516297 A (1992); Chem. Abstr. 119, 8821 (1993).
42. H. Biere and W. Seelen, Leibigs Ann. Chem., 1972 (1976).
43. G. M. Coppola and G. E. Hardtmann, J. Heterocyclic Chem., 16, 1605 (1979).
44. A. Godard, G. Queguiner and P. Pastour, Bull. Soc. Chim. France, 1588 (1972).
45. T. M. Bare, R. B. Sparks, J. R. Empfield, T. W. Davenport and J. A. McKinney, World Patent 9511244 A1 (1995); Chem. Abstr., 123, 313994 (1995).
46. J. A. Blair and R. J. Gardner, J. Chem. Soc. (C), 1714 (1970).
47. D. Xue, Z.-G. Huang, K. Barnes, H. J. Lesiuk, K. E. Smith and A. M. Buchan, J. Cereb. Blood Flow Metab., 14, 251 (1994).
48. Panlabs, Incorporated, 11804 North Creek Parkway South, Bothell, WA 98011-8805.
49. J. F. W. Keana, S. M. Kher, S. X. Cai, C. M. Dinsmore, A. G. Glenn, J. Guastella, J. C. Huang, Y. Lu, V. Ilyin, P. L. Mouser, R. M. Woodward and E. Weber, J. Med. Chem., 38, 4367 (1995).
50. K. Takano, T. Tatlisumak, J. E. Formato, R. A. D. Carano, A. G. Bergmann, L. M. Pullan, T. M. Bare, C. H. Sotak and M. Fisher, Stroke, 28, 1255 (1997).
51. [51a] H. Qui, L. W. Hedlund, S. L. Gewalt, H. Benveniste, T. M. Bare and G. A. Johnson, J. Magn. Reson. Imaging, 7, 739 (1997);
52. [b] H. Qui, L. W. Hedlund, H. Benveniste, S. L. Gewalt and G. A. Johnson, Magn. Reson. Med., 4, 505 (1996).
53. Unpublished observations by Dr. Chung Y. Hsu, Department of Neurology, Washington University School of Medicine, St. Louis, MO 63110.
54. S. Sagratella, A. Pezzola, P. Popoli and A. S. Scotti de Carolis, Psychopharmacol., 109, 277 (1992).
55. M. A. Yenari, T. E. Bell, A. N. Kotake, M. Powell and G. K. Steinberg, Clin. Neuropharmacol., 21, 28 (1998).
56. K. W. Muir, D. G. Grosset and K. R. Lees, Clin. Neuropharmacol., 20, 311 (1997).
57. R. J. Hargreaves, R. G. Hill and L. L. Iversen, Acta. Neurochir. Suppl., 60, 15 (1994).
58. J. W. Olney, J. Labruyere, G. Wang, D. F. Wozniak, M. T. Price and M. A. Sesma, Science, 254, 1515 (1991).